Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Arch Sex Behav. 2019 Oct 19;49(1):195–209. doi: 10.1007/s10508-019-01515-x

Table 1.

Sociodemographic, HIV care, and behavioral characteristics of recruited participants, by drug use status (n=765 a)

Total n=765 N (%) Non-drug users n=208 n (%) Other drug users n=291 n (%) Stimulant drug users n=266 n (%) p value b
Age, n=764 c 0.130
 18 – 29 years 155 (20.3) 48 (23.1) 53 (18.3) 54 (20.3)
 30 – 39 years 232 (30.4) 63 (30.3) 85 (29.3) 84 (31.6)
 40 – 49 years 221 (28.9) 57 (27.4) 78 (26.9) 86 (32.3)
 ≥ 50 years 156 (20.4) 40 (19.2) 74 (25.5) 42 (15.8)
Race, n=765 <0.001
 White 521 (68.1) 124 (59.6) 210 (72.2) 187 (70.3)
 Black 124 (16.2) 51 (24.5) 45 (15.5) 28 (10.5)
 Hispanic 120 (15.7) 33 (15.9) 36 (12.4) 51 (19.2)
Education, n=762 c 0.290
 Less than a college graduate 382 (50.1) 104 (50.2) 136 (46.9) 142 (53.6)
 College graduate or higher 380 (49.9) 103 (49.8) 154 (53.1) 123 (46.4)
Employment status, n=754 c <0.001
 Not working full time 311 (41.3) 69 (34.2) 98 (33.8) 144 (55.0)
 Working full time 443 (58.8) 133 (65.8) 192 (66.2) 118 (45.0)
Income, n=742 c 0.002
 < $20,000 225 (30.3) 54 (27.7) 71 (24.7) 100 (38.5)
 $20,000 - $59,999 319 (43.0) 88 (45.1) 124 (43.2) 107 (41.2)
 ≥ $60,000 198 (26.7) 53 (27.2) 92 (32.1) 53 (20.4)
Alcohol use disorder, n=638 c 0.163
 No 380 (59.6) 96 (64.4) 148 (55.4) 136 (61.3)
 Yes 258 (40.4) 53 (35.6) 119 (44.6) 86 (38.7)
Past 3 month injection drug use, n=557 c -- d
 No 451 (81.0) 0 (0.0) 291 (100.0) 160 (60.2)
 Yes 106 (19.0) 0 (0.0) 0 (0.0) 106 (39.8)
Past 3 month male anal sex partners, n=754 c <0.001
 0 partners 115 (15.3) 56 (27.2) 40 (13.8) 19 (7.3)
 1 – 4 partners 415 (55.0) 117 (56.8) 168 (58.1) 130 (50.2)
 ≥ 5 partners 224 (29.7) 33 (16.0) 81 (28.0) 110 (42.5)
Past 3 month male anal sex with SD partner, n=637 c 0.136
 No 108 (16.9) 29 (19.6) 33 (13.2) 46 (19.2)
 Confirmed / Unknown 529 (83.1) 119 (80.4) 216 (86.8) 194 (80.8)
Past 3 month CAS with male SD partner, n=514 c <0.001
 No 41 (8.0) 19 (16.7) 14 (6.6) 8 (4.2)
 Yes 473 (92.0) 95 (83.3) 197 (93.4) 181 (95.8)
Past 3 month STI diagnosis, n=756 c <0.001
 No 622 (82.3) 179 (87.8) 246 (85.1) 197 (74.9)
 Yes 134 (17.7) 25 (12.2) 43 (14.9) 66 (25.1)
Engaged in HIV care, n=757 c 0.634
 No 69 (9.1) 19 (9.5) 23 (7.9) 27 (10.2)
 Yes 688 (90.9) 182 (90.6) 268 (92.1) 238 (89.8)
Last HIV care visit, n=687 c 0.079
 < 6 months 627 (91.3) 169 (92.9) 250 (93.4) 208 (87.8)
 6 – 12 months 50 (7.3) 9 (5.0) 17 (6.3) 24 (10.1)
 > 12 months 10 (1.5) 4 (2.2) 1 (0.4) 5 (2.1)
ART adherence, n=762 c <0.001
 Not currently on ART 60 (7.9) 18 (8.7) 13 (4.5) 29 (10.9)
 Suboptimal adherence 361 (47.4) 81 (39.1) 126 (43.5) 154 (58.1)
 High adherence 341 (44.8) 108 (52.2) 151 (52.1) 82 (30.9)
Self-reported HIV viral load, n=672 c <0.001
 Undetectable (<=200 copies/ml) 616 (91.7) 168 (92.8) 258 (95.9) 190 (85.6)
 Detectable (>200 copies/ml) 56 (8.3) 13 (7.2) 11 (4.1) 32 (14.4)

Abbreviations: SD, serodiscordant; CAS, condomless anal sex; ART, antiretroviral therapy.

Notes: Column percentages presented; percentages may exceed 100% due to rounding.

a

A total of 766 participants were recruited. One participant with missing drug use data was excluded from all analyses.

b

Chi-square test.

c

Denominators vary due to missing data or survey skip pattern.

d

Test statistic not computed due to 0 values in multiple categories.